Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Harbor Diversified, Inc. (HRBR)
USD2.05
+0.00 (+0.00%)
US OTC Healthcare Medical - Pharmaceuticals
Address
W6390 Challenger Drive 54914-9120
Appleton, WI, US
Appleton, WI, US
CEO
Christine R. Deister
Website
harborcustomdev.com
IPO
1997-09-08
CIK 899394 ISIN US41150R1023
Description
Harbor Diversified, Inc. provides regional air services in the United States. The company leases flight equipment; and provides flight equipment financing. As of December 31, 2023, it owned and operated a fleet of 63 regional jets. Harbor Diversified, Inc. is headquartered in Appleton, Wisconsin.
Market Cap & Enterprise Value
Merger & Acquisition History
| Target company | Ticker | Date | Filing |
|---|---|---|---|
| Hollis-Eden | IACQ | 1996-12-24 | View |
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
USD2.05
+0.00 (+0.00%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
64.2K
Beta
0.54
Float Shares
38.43M
Free Float %
65.8%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +1.20% | +8.39% | +5.00% | +15.86% | +76.84% | +1.82% | +354.05% | -28.81% | -1.75% | +2,700.00% | -81.08% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Price Targets & DCF
Current price
2.05
DCF (Unlevered)
21.31
+939.5%
DCF (Levered)
16.20
+690.2%
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
Ratings Trend (MoM)
| Rating | 2024-11 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 0 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
Quality scores
Altman Z-Score
1.50
Distress
Piotroski F-Score
5 / 9
Average
MOAT Score
0 / 10
No MOAT
Operational MOAT
✗ Below peers
-
Revenue growth Medical - Pharmaceuticals: +7.8%-29.1% Q3'25: -97.9% (vs Q1'24)
-
EPS growth Medical - Pharmaceuticals: +20.2%-163.9% Q3'25: +60.9% (vs Q1'24)
-
FCF margin FCF growth · Medical - Pharmaceuticals: +43.3%-1.4% Q3'25: -2,407.1% (vs Q1'24)
-
EBIT margin Medical - Pharmaceuticals: +6.8%-9.7% Q3'25: +0.0% (vs Q1'24)
-
ROIC Medical - Pharmaceuticals: +6.1%-25.7% Q3'25: +0.0% (vs Q1'24)
-
Share dilution Medical - Pharmaceuticals: +0.0%-30.0% ★ Q3'25: +36.2% (vs Q1'24)
-
Debt / EBITDA Net debt/EBITDA · Medical - Pharmaceuticals: 0.21×1.18× ★ Q3'25: -0.11× (vs Q1'24)
Valuation Multiples
From
To
Price Forecast (3Y)
From
To
Theoretical Return — If Invested Today
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
Consensus Estimates
| Metric |
Dec 2009 actual |
Dec 2010 actual |
|---|---|---|
| Revenue |
—
est: 5.00M (-100.0%)
|
—
est: 112.50M (-100.0%)
|
| EBITDA |
-15.42M
est: 1.33M (-1,262.1%)
|
-6.58M
est: 29.85M (-122.0%)
|
| EBIT |
-15.63M
est: 752.4K (-2,176.9%)
|
-6.60M
est: 16.93M (-139.0%)
|
| Net Income |
-15.63M
|
-6.60M
|
| SGA |
5.14M
est: 101.5K (+4,962.3%)
|
2.77M
est: 2.28M (+21.3%)
|
| EPS |
-0.53
|
-0.20
|
Owner Earnings
Owner's Earnings (history)
From
To
Owner alignment
Owner's Earnings TTM
-20.29M
OE per share TTM
2.27
Owner's Yield
-2,062.06%
Maintenance CapEx ratio
—
Maint CapEx / Avg PPE
59.0%
Ownership Overview
Ownership breakdown
At a glance
Institutional holders
1
Total invested
30.6K
Insider transactions (90d)
0
Beneficial owners (>5%)
14
Beneficial owners (>5%)
| # | Reporting person | Amount owned | % of class | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Type | Citizenship | Filing date | SEC filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | HOLLIS | 4.18M | 20.20% | — | — | — | — | IN | UNITED STATES | 2004-01-26 | ↗ |
| 2 | RICHARD B. HOLLIS | 3.88M | 12.60% | 3.88M | — | 3.88M | — | IN | UNITED STATES | 2009-01-20 | ↗ |
| 3 | Robert E. Petersen | 1.40M | 10.80% | 16.5K | 1.39M | 16.5K | 1.39M | IN | United States | 2003-01-23 | ↗ |
| 4 | Margaret M. Petersen | 1.39M | 10.80% | — | 1.39M | — | 1.39M | IN | United States | 2003-01-23 | ↗ |
| 5 | R.E. & M. Petersen Living Trust Dated 1/17/83 | 1.39M | 10.80% | — | 1.39M | — | 1.39M | OO | United States | 2003-01-23 | ↗ |
| 6 | Cranshire Capital, L.P. | 1.33M | 6.90% | 1.33M | — | — | — | PN | Illinois | 2005-06-06 | ↗ |
| 7 | Downsview Capital, Inc. | 1.33M | 6.90% | 1.33M | — | — | — | CO | Illinois | 2005-06-06 | ↗ |
| 8 | Mitchell P. Kopin | 1.33M | 6.90% | 1.33M | — | — | — | IN | Illinois | 2005-06-06 | ↗ |
| 9 | Security Management Company, LLC 48-1183041 | 1.19M | 6.15% | 1.19M | — | 1.19M | — | IA | A limited liability company organized under the laws of the State of Kansas. | 2005-02-14 | ↗ |
| 10 | Abigail P. Johnson | 619.4K | 3.21% | — | — | 619.4K | — | IN | United States of America | 2005-02-14 | ↗ |
| 11 | Edward C. Johnson 3d | 619.4K | 3.21% | — | — | 619.4K | — | IN | United States of America | 2005-02-14 | ↗ |
| 12 | FMR Corp. | 619.4K | 3.21% | 46.7K | — | 619.4K | — | HC | Delaware | 2005-02-14 | ↗ |
| 13 | U.S. Bancorp | 2.7K | 0.01% | 2.7K | — | 2.7K | — | HC | Delaware, U.S.A. | 2005-01-31 | ↗ |
| 14 | U.S. Bancorp Asset Management, Inc. | 2.7K | 0.01% | 2.7K | — | 2.7K | — | IA | Delaware, U.S.A. | 2005-01-31 | ↗ |
Institutional Activity (13F)
Institutional ownership trend
From
To
13F snapshot — 2026 Q1
Investors holding
1
+0 vs prev Q
New positions
0
Closed positions
0
Increased
0
Reduced
0
Put/Call ratio
0.00
Calls held
—
Puts held
—
Top institutional holders
| # | Investor | Shares / Δ | Mkt value / Δ | Own% / Δ | Weight% / Δ | Avg px / Perf. | Hold / Status |
|---|---|---|---|---|---|---|---|
| 1 | WILLIAMS JONES WEALTH MANAGEMENT, LLC. | 20.0K +— (+0.0%) | 30.6K -2.4K (-7.3%) | 3.42% +0.000 pp | 0.00% +0.000 pp | USD1.88 -18.6% | 19 qtrs — |
Ownership breakdown by holder
ETF Ownership
Top ETFs holding this stock
This company is not held by any ETF in our universe.
Insider Activity
Insider Activity — Latest Quarter
Ratio by transactions
0.00
Bearish
Buys
3
Sells
0
Shares acquired
75.0K
Shares disposed
—
Cash buys
3.00
Cash sales
—
Net activity
+75,000
Insider buys vs sells (history)
From
To
Recent insider transactions
From
To
| Date | Person | Role | Transaction | A/D | Security | Shares | Price | Value | Owned after | D/I | Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2011-10-28 | FRINCKE JAMES M | Director / Officer | P-Purchase | A | Common Stock | 25,000 | 0.16 | 4.0K | 994,672 | — | ↗ |
| 2011-10-27 | FRINCKE JAMES M | Director / Officer | P-Purchase | A | Common Stock | 25,000 | 0.16 | 4.0K | 969,672 | — | ↗ |
| 2011-10-18 | FRINCKE JAMES M | Director / Officer | P-Purchase | A | Common Stock | 25,000 | 0.13 | 3.3K | 944,672 | — | ↗ |
| 2011-08-11 | SHAW JOHN C | Director | — | I | Series A Preferred Stock | 14,000,000 | 0.00 | — | 0 | — | ↗ |
| 2011-08-11 | SESLOWE JERRY M | Director | — | I | Series A Preferred Stock | 14,000,000 | 0.00 | — | 0 | — | ↗ |
| 2011-08-11 | Bartlett Richard A | Director | — | I | Series A Preferred Stock | 14,000,000 | 0.00 | — | 0 | — | ↗ |
| 2010-01-29 | ZIZZA SALVATORE J | Director | A-Award | A | Stock Option (Right to Buy) | 40,000 | 1.00 | 40.0K | 40,000 | — | ↗ |
| 2010-01-29 | WEBER ROBERT W | Officer | A-Award | A | Stock Option (Right to Buy) | 100,000 | 1.00 | 100.0K | 100,000 | — | ↗ |
| 2010-01-29 | Sarni Marc R | Director | A-Award | A | Stock Option (Right to Buy) | 30,000 | 1.00 | 30.0K | 30,000 | — | ↗ |
| 2010-01-29 | STICKNEY DWIGHT | Officer | A-Award | A | Stock Option (Right to Buy) | 100,000 | 1.00 | 100.0K | 100,000 | — | ↗ |
| 2010-01-29 | READING CHRISTOPHER | Officer | A-Award | A | Stock Option (Right to Buy) | 100,000 | 1.00 | 100.0K | 100,000 | — | ↗ |
| 2010-01-29 | Hauer Jerome M | Director | A-Award | A | Stock Option (Right to Buy) | 30,000 | 1.00 | 30.0K | 30,000 | — | ↗ |
| 2010-01-29 | FRINCKE JAMES M | Director / Officer | A-Award | A | Stock Option (Right to Buy) | 200,000 | 1.00 | 200.0K | 200,000 | — | ↗ |
| 2009-06-11 | MARSELLA ROBERT | Officer | A-Award | A | Stock Option (Right to Buy) | 30,000 | 6.50 | 195.0K | 30,000 | — | ↗ |
| 2008-02-01 | STICKNEY DWIGHT | Officer | — | D | Common Stock | 0 | 0.00 | — | 11,673 | — | ↗ |
| 2008-01-28 | ZIZZA SALVATORE J | Director | A-Award | A | Stock Option (Right to Buy) | 20,000 | 1.62 | 32.4K | 20,000 | — | ↗ |
| 2008-01-28 | Sarni Marc R | Director | A-Award | A | Stock Option (Right to Buy) | 15,000 | 1.62 | 24.3K | 15,000 | — | ↗ |
| 2008-01-28 | MERIGAN THOMAS | Director | A-Award | A | Stock Option (Right to Buy) | 10,000 | 1.62 | 16.2K | 10,000 | — | ↗ |
| 2008-01-28 | MCDONNELL BRENDAN | Director | A-Award | A | Stock Option (Right to Buy) | 15,000 | 1.62 | 24.3K | 15,000 | — | ↗ |
| 2008-01-28 | Hauer Jerome M | Director | A-Award | A | Stock Option (Right to Buy) | 15,000 | 1.62 | 24.3K | 15,000 | — | ↗ |
| 2008-01-17 | ZIZZA SALVATORE J | Director | A-Award | A | Stock Option (Right to Buy) | 20,000 | 1.62 | 32.4K | 20,000 | — | ↗ |
| 2008-01-17 | WEBER ROBERT W | Officer | A-Award | A | Stock Option (Right to Buy) | 30,350 | 2.25 | 68.3K | 30,350 | — | ↗ |
| 2008-01-17 | STICKNEY DWIGHT | Officer | — | D | Stock Options (Right to Buy) | 25,000 | 1.62 | 40.5K | 0 | — | ↗ |
| 2008-01-17 | READING CHRISTOPHER | Officer | A-Award | A | Stock Option (Right to Buy) | 25,000 | 1.62 | 40.5K | 25,000 | — | ↗ |
| 2008-01-17 | MERIGAN THOMAS | Director | A-Award | A | Stock Option (Right to Buy) | 10,000 | 1.62 | 16.2K | 10,000 | — | ↗ |
| 2008-01-17 | MCDONNELL BRENDAN | Director | A-Award | A | Stock Option (Right to Buy) | 15,000 | 1.62 | 24.3K | 15,000 | — | ↗ |
| 2008-01-17 | MARSELLA ROBERT | Officer | A-Award | A | Stock Option (Right to Buy) | 25,000 | 1.62 | 40.5K | 25,000 | — | ↗ |
| 2008-01-17 | HOLLIS RICHARD B | Director / Officer / 10% Owner | A-Award | A | Stock Option (Right to Buy) | 500,000 | 1.62 | 810.0K | 500,000 | — | ↗ |
| 2008-01-17 | FRINCKE JAMES M | Officer | A-Award | A | Stock Option (Right to Buy) | 3,000 | 1.62 | 4.9K | 3,000 | — | ↗ |
| 2008-01-17 | FREEMAN SCOTT M | Officer | A-Award | D | Stock Option (Right to Buy) | 15,000 | 1.62 | 24.3K | 15,000 | — | ↗ |
| 2007-09-18 | MERIGAN THOMAS | Director | D-Return | D | Stock Option (Right to Buy) | 125,000 | 2.25 | 281.3K | 0 | — | ↗ |
| 2007-08-01 | WEBER ROBERT W | Officer | A-Award | A | Stock Option (Right to Buy) | 100,000 | 1.66 | 166.0K | 100,000 | — | ↗ |
| 2007-08-01 | STICKNEY DWIGHT | Officer | — | D | Stock Options (Right to Buy) | 100,000 | 1.66 | 166.0K | 0 | — | ↗ |
| 2007-08-01 | READING CHRISTOPHER | Officer | A-Award | D | Stock Option (Right to Buy) | 100,000 | 1.66 | 166.0K | 100,000 | — | ↗ |
| 2007-08-01 | MARSELLA ROBERT | Officer | A-Award | A | Stock Option (Right to Buy) | 120,000 | 1.66 | 199.2K | 120,000 | — | ↗ |
| 2007-08-01 | HOLLIS RICHARD B | Director / Officer / 10% Owner | A-Award | A | Stock Option (Right to Buy) | 100,000 | 5.00 | 500.0K | 100,000 | — | ↗ |
| 2007-08-01 | FRINCKE JAMES M | Officer | A-Award | A | Stock Option (Right to Buy) | 200,000 | 1.66 | 332.0K | 200,000 | — | ↗ |
| 2007-08-01 | FREEMAN SCOTT M | Officer | A-Award | D | Stock Option (Right to Buy) | 150,000 | 1.66 | 249.0K | 150,000 | — | ↗ |
| 2007-03-05 | WEBER ROBERT W | Officer | S-Sale | D | Common Stock | 300 | 5.30 | 1.6K | 24,290 | — | ↗ |
| 2007-02-14 | READING CHRISTOPHER | Officer | S-Sale | D | Common Stock | 186 | 5.48 | 1.0K | 9,283 | — | ↗ |
| 2007-02-14 | LOUMEAU ERIC J | Officer | S-Sale | D | Common Stock | 186 | 5.52 | 1.0K | 8,902 | — | ↗ |
| 2007-02-14 | BURGESS DANIEL D | Officer | S-Sale | D | Common Stock | 1,655 | 5.50 | 9.1K | 12,609 | — | ↗ |
| 2007-02-13 | FRINCKE JAMES M | Officer | S-Sale | D | Common Stock | 112 | 5.76 | 645.12 | 13,611 | — | ↗ |
| 2007-02-05 | WEBER ROBERT W | Officer | S-Sale | D | Common Stock | 1,200 | 5.40 | 6.5K | 23,990 | — | ↗ |
| 2007-01-08 | WEBER ROBERT W | Officer | M-Exempt | D | Stock Option (Right to Buy) | 3,000 | 2.25 | 6.8K | 0 | — | ↗ |
| 2006-12-12 | MCDONNELL BRENDAN | Director | P-Purchase | A | Common Stock | 6,360 | 5.82 | 37.0K | 10,000 | — | ↗ |
| 2006-12-11 | ZIZZA SALVATORE J | Director | A-Award | A | Stock Option (Right to Buy) | 30,000 | 0.00 | — | 30,000 | — | ↗ |
| 2006-12-11 | WEBER ROBERT W | Officer | A-Award | A | Stock Option (Right to Buy) | 25,000 | 5.43 | 135.8K | 25,000 | — | ↗ |
| 2006-12-11 | Sarni Marc R | Director | A-Award | A | Stock Option (Right to Buy) | 15,000 | 5.43 | 81.5K | 15,000 | — | ↗ |
| 2006-12-11 | STICKNEY DWIGHT | Officer | — | D | Stock Options (Right to Buy) | 25,000 | 5.43 | 135.8K | 0 | — | ↗ |
| 2006-12-11 | READING CHRISTOPHER | Officer | A-Award | D | Stock Option (Right to Buy) | 25,000 | 5.43 | 135.8K | 25,000 | — | ↗ |
| 2006-12-11 | MERIGAN THOMAS | Director | A-Award | A | Stock Option (Right to Buy) | 10,000 | 5.43 | 54.3K | 10,000 | — | ↗ |
| 2006-12-11 | MCDONNELL BRENDAN | Director | A-Award | A | Stock Option (Right to Buy) | 15,000 | 5.43 | 81.5K | 15,000 | — | ↗ |
| 2006-12-11 | MARSELLA ROBERT | Officer | A-Award | A | Stock Option (Right to Buy) | 25,000 | 5.43 | 135.8K | 25,000 | — | ↗ |
| 2006-12-11 | LOUMEAU ERIC J | Officer | A-Award | A | Stock Option (Right to Buy) | 25,000 | 5.43 | 135.8K | 25,000 | — | ↗ |
| 2006-12-11 | Hauer Jerome M | Director | A-Award | A | Stock Option (Right to Buy) | 15,000 | 5.43 | 81.5K | 15,000 | — | ↗ |
| 2006-12-11 | HOLLIS RICHARD B | Officer | A-Award | A | Stock Option (Right to Buy) | 160,000 | 0.00 | — | 160,000 | — | ↗ |
| 2006-12-11 | FRINCKE JAMES M | Officer | A-Award | A | Stock Option (Right to Buy) | 3,100 | 5.43 | 16.8K | 3,100 | — | ↗ |
| 2006-12-11 | BURGESS DANIEL D | Officer | A-Award | A | Stock Option (Right to Buy) | 50,000 | 5.43 | 271.5K | 50,000 | — | ↗ |
| 2006-12-11 | BAGLEY PAUL | Director | A-Award | A | Stock Option (Right to Buy) | 15,000 | 5.43 | 81.5K | 15,000 | — | ↗ |
| 2006-12-08 | Sarni Marc R | Director | P-Purchase | A | Common Stock | 5,000 | 5.40 | 27.0K | 5,000 | — | ↗ |
| 2006-12-01 | ZIZZA SALVATORE J | Director | A-Award | A | Stock Option (Right to Buy) | 3,000 | 5.52 | 16.6K | 3,000 | — | ↗ |
| 2006-08-21 | WEBER ROBERT W | Officer | M-Exempt | A | Common Stock | 650 | 2.25 | 1.5K | 22,832 | — | ↗ |
| 2006-04-10 | ZIZZA SALVATORE J | Director | A-Award | A | Stock Option (Right to Buy) | 30,000 | 5.52 | 165.6K | 30,000 | — | ↗ |
| 2006-03-13 | WEBER ROBERT W | Officer | M-Exempt | A | Common Stock | 18,200 | 2.25 | 41.0K | 39,537 | — | ↗ |
| 2006-03-10 | MCDONNELL BRENDAN | Director | S-Sale | D | Common Stock | 5,000 | 6.29 | 31.4K | 0 | — | ↗ |
| 2006-02-14 | ZIZZA SALVATORE J | Director | A-Award | A | Stock Option (Right to Buy) | 15,000 | 6.19 | 92.9K | 15,000 | — | ↗ |
| 2006-02-14 | Sarni Marc R | Director | A-Award | A | Stock Option (Right to Buy) | 15,000 | 6.19 | 92.9K | 15,000 | — | ↗ |
| 2006-02-14 | MCDONNELL BRENDAN | Director | A-Award | A | Stock Option (Right to Buy) | 15,000 | 6.19 | 92.9K | 15,000 | — | ↗ |
| 2006-02-14 | Hauer Jerome M | Director | A-Award | A | Stock Option (Right to Buy) | 15,000 | 6.19 | 92.9K | 15,000 | — | ↗ |
| 2006-02-14 | BAGLEY PAUL | Director | A-Award | A | Stock Option (Right to Buy) | 15,000 | 6.19 | 92.9K | 15,000 | — | ↗ |
| 2006-02-13 | WEBER ROBERT W | Officer | A-Award | A | Stock Option (Right to Buy) | 11,250 | 6.20 | 69.8K | 11,250 | — | ↗ |
| 2006-02-13 | STICKNEY DWIGHT | Officer | — | D | Stock Options (Right to Buy) | 11,250 | 6.20 | 69.8K | 0 | — | ↗ |
| 2006-02-13 | READING CHRISTOPHER | Officer | A-Award | A | Common Stock | 3,750 | 0.00 | — | 8,397 | — | ↗ |
| 2006-02-13 | MARSELLA ROBERT | Officer | A-Award | A | Common Stock | 3,750 | 0.00 | — | 17,407 | — | ↗ |
| 2006-02-13 | LOUMEAU ERIC J | Officer | A-Award | A | Stock Option (Right to Buy) | 11,250 | 6.20 | 69.8K | 11,250 | — | ↗ |
| 2006-02-13 | HOLLIS RICHARD B | Director / Officer / 10% Owner | A-Award | A | Common Stock | 24,000 | 0.00 | — | 2,290,499 | — | ↗ |
| 2006-02-13 | FRINCKE JAMES M | Officer | A-Award | A | Stock Option (Right to Buy) | 27,000 | 6.20 | 167.4K | 27,000 | — | ↗ |
| 2006-02-13 | BURGESS DANIEL D | Officer | A-Award | A | Common Stock | 9,000 | 0.00 | — | 13,256 | — | ↗ |
| 2006-01-30 | MCDONNELL BRENDAN | Director | M-Exempt | D | Stock Option (Right to Buy) | 5,000 | 2.25 | 11.3K | 5,000 | — | ↗ |
| 2005-09-29 | LOUMEAU ERIC J | Officer | M-Exempt | A | Common Stock | 500 | 6.50 | 3.3K | 1,300 | — | ↗ |
| 2005-09-26 | LOUMEAU ERIC J | Officer | S-Sale | D | Common Stock | 1,000 | 10.00 | 10.0K | 800 | — | ↗ |
| 2005-09-12 | WEBER ROBERT W | Officer | M-Exempt | A | Common Stock | 2,200 | 2.25 | 5.0K | 19,252 | — | ↗ |
| 2005-09-12 | MCDONNELL BRENDAN | Director | M-Exempt | D | Stock Option (Right to Buy) | 5,000 | 2.25 | 11.3K | 10,000 | — | ↗ |
| 2005-08-12 | WEBER ROBERT W | Officer | M-Exempt | A | Common Stock | 1,800 | 2.25 | 4.1K | 18,852 | — | ↗ |
| 2005-08-10 | MCDONNELL BRENDAN | Director | S-Sale | D | Common Stock | 5,000 | 8.95 | 44.7K | 0 | — | ↗ |
| 2005-07-21 | WEBER ROBERT W | Officer | M-Exempt | A | Common Stock | 1,600 | 2.25 | 3.6K | 18,652 | — | ↗ |
| 2005-07-11 | MCDONNELL BRENDAN | Director | M-Exempt | D | Stock Option (Right to Buy) | 5,000 | 2.25 | 11.3K | 20,000 | — | ↗ |
| 2005-06-17 | MERIGAN THOMAS | Director | A-Award | A | Options | 15,000 | 10.75 | 161.3K | 15,000 | — | ↗ |
| 2005-06-17 | MCDONNELL BRENDAN | Director | A-Award | A | Options | 15,000 | 10.75 | 161.3K | 15,000 | — | ↗ |
| 2005-05-16 | WEBER ROBERT W | Officer | M-Exempt | D | Stock Option (Right to Buy) | 1,200 | 2.25 | 2.7K | 23,800 | — | ↗ |
| 2005-02-11 | WEBER ROBERT W | Officer | A-Award | A | Stock Option | 19,500 | 10.75 | 209.6K | 19,500 | — | ↗ |
| 2005-02-11 | STICKNEY DWIGHT | Officer | — | D | Stock Options (Right to Buy) | 19,500 | 10.75 | 209.6K | 0 | — | ↗ |
| 2005-02-11 | READING CHRISTOPHER | Officer | A-Award | D | Stock Option | 19,500 | 10.75 | 209.6K | 19,500 | — | ↗ |
| 2005-02-11 | MARSELLA ROBERT | Officer | A-Award | A | Stock Option | 19,500 | 10.75 | 209.6K | 19,500 | — | ↗ |
| 2005-02-11 | LOUMEAU ERIC J | Officer | A-Award | A | Stock Option | 19,500 | 10.75 | 209.6K | 19,500 | — | ↗ |
| 2005-02-11 | HOLLIS RICHARD B | Director / Officer / 10% Owner | A-Award | A | Stock Options | 124,800 | 10.75 | 1.34M | 124,800 | — | ↗ |
| 2005-02-11 | FRINCKE JAMES M | Officer | A-Award | A | Stock Option | 46,800 | 10.75 | 503.1K | 46,800 | — | ↗ |
| 2005-02-11 | BURGESS DANIEL D | Officer | A-Award | A | Stock Option | 39,000 | 10.75 | 419.3K | 39,000 | — | ↗ |
| 2004-12-03 | STICKNEY DWIGHT | Officer | — | D | Stock Options (Right to Buy) | 6,000 | 10.69 | 64.1K | 0 | — | ↗ |
| 2004-11-11 | HOLLIS RICHARD B | Director / Officer / 10% Owner | D-Return | D | Common Stock | 400,000 | 10.25 | 4.10M | 2,264,341 | — | ↗ |
| 2004-06-24 | Groothuis Jessie R | Officer | A-Award | A | Options | 50,000 | 11.70 | 585.0K | 50,000 | — | ↗ |
| 2004-06-18 | ZIZZA SALVATORE J | Director | A-Award | A | Stock Options | 10,000 | 11.75 | 117.5K | 10,000 | — | ↗ |
| 2004-06-18 | Sarni Marc R | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2004-06-18 | MERIGAN THOMAS | Director | A-Award | A | Options | 5,000 | 11.75 | 58.8K | 5,000 | — | ↗ |
| 2004-06-18 | MCDONNELL BRENDAN | Director | A-Award | A | Options | 5,000 | 11.75 | 58.8K | 5,000 | — | ↗ |
| 2004-06-18 | Hauer Jerome M | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2004-06-18 | Groothuis Jessie R | Officer | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2004-06-18 | BAGLEY PAUL | Director | A-Award | A | Options | 15,000 | 11.75 | 176.3K | 15,000 | — | ↗ |
| 2004-01-16 | WEBER ROBERT W | Officer | A-Award | A | Stock Options | 25,000 | 14.97 | 374.3K | 25,000 | — | ↗ |
| 2004-01-16 | STICKNEY DWIGHT | Officer | A-Award | A | Stock Options | 28,000 | 14.97 | 419.2K | 28,000 | — | ↗ |
| 2004-01-16 | READING CHRISTOPHER | Officer | A-Award | A | Stock Options | 31,000 | 14.97 | 464.1K | 31,000 | — | ↗ |
| 2004-01-16 | MARSELLA ROBERT | Officer | A-Award | A | Stock Options | 25,000 | 14.97 | 374.3K | 25,000 | — | ↗ |
| 2004-01-16 | LOUMEAU ERIC J | Officer | A-Award | A | Stock Options | 25,000 | 14.97 | 374.3K | 25,000 | — | ↗ |
| 2004-01-16 | HOLLIS RICHARD B | Officer | A-Award | A | Stock Options | 160,000 | 14.97 | 2.40M | 160,000 | — | ↗ |
| 2004-01-16 | FRINCKE JAMES M | Officer | A-Award | A | Stock Options | 64,000 | 14.97 | 958.1K | 64,000 | — | ↗ |
| 2004-01-16 | BURGESS DANIEL D | Officer | A-Award | A | Stock Options | 50,000 | 14.97 | 748.5K | 50,000 | — | ↗ |
| 2003-12-22 | BAGLEY PAUL | Director | P-Purchase | A | Common Stock | 2,200 | 10.17 | 22.4K | 62,380 | — | ↗ |
| 2003-10-22 | STICKNEY DWIGHT | Director / Officer | P-Purchase | A | Common Stock | 2,286 | 18.54 | 42.4K | 2,286 | — | ↗ |
| 2003-10-17 | STICKNEY DWIGHT | Director / Officer | S-Sale | D | Common Stock | 2,267 | 17.51 | 39.7K | 0 | — | ↗ |
| 2003-06-26 | STICKNEY DWIGHT | Officer | — | D | Stock Options (Right to Buy) | 1,000 | 12.20 | 12.2K | 0 | — | ↗ |
| 2003-06-25 | STICKNEY DWIGHT | Director / Officer | A-Award | A | Options | 1,000 | 12.25 | 12.3K | 1,000 | — | ↗ |
| 2003-06-25 | READING CHRISTOPHER | Officer | A-Award | A | Options | 10,000 | 12.25 | 122.5K | 10,000 | — | ↗ |
| 2003-06-25 | HOLLIS RICHARD B | Director / Officer / 10% Owner | A-Award | A | Stock Options | 80,000 | 12.25 | 980.0K | 80,000 | — | ↗ |
| 2003-06-25 | FRINCKE JAMES M | Officer | A-Award | A | Options | 10,000 | 12.25 | 122.5K | 10,000 | — | ↗ |
| 2003-02-26 | STICKNEY DWIGHT | Officer | — | D | Stock Options (Right to Buy) | 12,500 | 5.29 | 66.1K | 0 | — | ↗ |
| 2002-01-09 | STICKNEY DWIGHT | Officer | — | D | Stock Options (Right to Buy) | 12,500 | 9.91 | 123.9K | 0 | — | ↗ |
| 2001-05-29 | STICKNEY DWIGHT | Officer | — | D | Stock Options (Right to Buy) | 36,000 | 6.90 | 248.4K | 0 | — | ↗ |
| 2000-06-23 | STICKNEY DWIGHT | Officer | — | D | Stock Options (Right to Buy) | 50,000 | 11.81 | 590.5K | 0 | — | ↗ |
Executive team
Top executives
EBIT / Employee
-20.5K
Shares Outstanding
58.43M
Executive compensation
Executive compensation (annual)
| # | Year | Executive | Salary | Bonus | Stock award | Option award | Incentive | Other | Total | % Stock- based |
Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 2010 | Dr. Christopher L. Reading Chief Scientific Officer | 325.0K | — | 574.00 | 182.8K | — | 17.7K | 526.1K | 34.85% | ↗ |
| 2 | 2010 | Robert W. Weber Chief Financial Officer | 371.4K | — | 239.00 | 84.9K | — | 8.0K | 464.5K | 18.32% | ↗ |
| 3 | 2010 | Dwight R. Stickney, M.D. Chief Medical Officer | 270.5K | — | 239.00 | 84.9K | — | 8.3K | 363.9K | 23.39% | ↗ |
| 4 | 2009 | Dwight R. Stickney, M.D. Chief Medical Officer Robert L. Marsella Senior Vice President, Business Development and Marketing | 371.4K | — | 516.00 | — | — | 37.4K | 379.6K | 0.14% | ↗ |
| 5 | 2009 | Dwight R. Stickney, M.D. Chief Medical Officer | 371.4K | — | 516.00 | — | — | 37.4K | 379.6K | 0.14% | ↗ |
| 6 | 2009 | Dr. James M. Frincke Chief Executive Officer Dr. Christopher L. Reading Chief Scientific Officer | 325.0K | — | 1.2K | — | — | 20.1K | 346.3K | 0.36% | ↗ |
| 7 | 2009 | Dr. James M. Frincke Chief Executive Officer | 325.0K | — | 1.2K | — | — | 20.1K | 346.3K | 0.36% | ↗ |
| 8 | 2009 | Dr. Christopher L. Reading Chief Scientific Officer Dwight R. Stickney, M.D. Chief Medical Officer | 270.5K | — | 516.00 | — | — | 21.3K | 279.3K | 0.18% | ↗ |
| 9 | 2009 | Dr. Christopher L. Reading Chief Scientific Officer | 270.5K | — | 516.00 | — | — | 21.3K | 279.3K | 0.18% | ↗ |
| 10 | 2009 | Robert W. Weber Chief Financial Officer | 235.0K | — | 516.00 | — | — | 39.0K | 259.5K | 0.20% | ↗ |
| 11 | 2009 | Robert L. Marsella Senior Vice President, Business Development and Marketing Robert W. Weber Chief Financial Officer | 205.4K | — | 516.00 | — | — | 17.4K | 209.3K | 0.25% | ↗ |
| 12 | 2009 | Richard B. Hollis Former Chairman of the Board and Chief Executive Officer Dr. James M. Frincke Chief Executive Officer | 121.8K | — | 1.9K | — | — | 44.4K | 168.0K | 1.11% | ↗ |
| 13 | 2008 | Richard B. Hollis Former Chairman of the Board and Chief Executive Officer | 553.8K | — | 10.4K | 810.0K | — | 43.6K | 1.42M | 57.87% | ↗ |
| 14 | 2008 | Richard B. Hollis Former Chairman of the Board and Chief Executive Officer Dr. James M. Frincke Interim Chief Executive Officer | 553.8K | — | 50.0K | 726.3K | — | 43.6K | 1.37M | 56.51% | ↗ |
| 15 | 2008 | Dr. James M. Frincke Interim Chief Executive Officer Dr. Christopher L. Reading Chief Scientific Officer | 325.0K | — | 18.7K | 319.7K | — | 23.6K | 687.0K | 49.27% | ↗ |
| 16 | 2008 | Dr. James M. Frincke Chief Executive Officer | 325.0K | — | 3.9K | 199.3K | — | 23.6K | 551.7K | 36.83% | ↗ |
| 17 | 2008 | Dwight R. Stickney, M.D. Chief Medical Officer Robert L. Marsella Senior Vice President, Business Development and Marketing | 371.4K | — | 7.8K | 111.2K | — | 5.5K | 495.8K | 24.00% | ↗ |
| 18 | 2008 | Robert W. Weber Interim Chief Financial Officer, Chief Accounting Officer and Vice President, Operations | 235.0K | — | 7.8K | 170.0K | — | 16.7K | 429.6K | 41.40% | ↗ |
| 19 | 2008 | Dwight R. Stickney, M.D. Chief Medical Officer | 371.4K | — | 1.6K | 40.5K | — | 5.5K | 419.0K | 10.06% | ↗ |
| 20 | 2008 | Robert L. Marsella Senior Vice President, Business Development and Marketing Robert W. Weber Interim Chief Financial Officer, Chief Accounting Officer and Vice President, Operations | 248.0K | — | 7.8K | 146.5K | — | 15.0K | 417.3K | 36.98% | ↗ |
| 21 | 2008 | Robert W. Weber Chief Financial Officer | 235.0K | — | 1.6K | 154.1K | — | 16.7K | 407.5K | 38.23% | ↗ |
| 22 | 2008 | Dr. Christopher L. Reading Chief Scientific Officer Dwight R. Stickney, M.D. Chief Medical Officer | 270.5K | — | 7.8K | 111.5K | — | 7.8K | 397.6K | 30.01% | ↗ |
| 23 | 2008 | Robert L. Marsella Senior Vice President, Business Development and Marketing | 248.0K | — | 1.6K | 81.0K | — | 15.0K | 345.6K | 23.91% | ↗ |
| 24 | 2008 | Dr. Christopher L. Reading Chief Scientific Officer | 270.5K | — | 1.6K | 40.5K | — | 7.8K | 320.4K | 13.15% | ↗ |
| 25 | 2007 | Richard B. Hollis Former Chairman of the Board and Chief Executive Officer | 532.5K | 266.2K | 38.3K | 1.53M | — | 19.7K | 2.39M | 65.74% | ↗ |
| 26 | 2007 | Dr. James M. Frincke Interim Chief Executive Officer | 298.5K | 59.7K | 15.3K | 361.3K | — | 7.7K | 742.4K | 50.72% | ↗ |
| 27 | 2007 | Richard B. Hollis Former Chairman of the Board and Chief Executive Officer Dr. James M. Frincke Chief Executive Officer | 298.5K | 59.7K | 14.4K | 332.0K | — | 7.7K | 712.2K | 48.63% | ↗ |
| 28 | 2007 | Dr. Christopher L. Reading Chief Scientific Officer Dwight R. Stickney, M.D. Chief Medical Officer | 357.1K | 71.4K | 6.0K | 166.0K | — | 5.9K | 606.4K | 28.36% | ↗ |
| 29 | 2007 | Dwight R. Stickney, M.D. Chief Medical Officer | 357.1K | 71.4K | 6.4K | 155.0K | — | 5.9K | 595.8K | 27.08% | ↗ |
| 30 | 2007 | Dr. James M. Frincke Chief Executive Officer Dr. Christopher L. Reading Chief Scientific Officer | 260.1K | 52.0K | 6.0K | 166.0K | — | 7.6K | 491.7K | 34.98% | ↗ |
| 31 | 2007 | Dr. Christopher L. Reading Chief Scientific Officer | 260.1K | 52.0K | 6.4K | 164.7K | — | 7.6K | 490.7K | 34.85% | ↗ |
| 32 | 2007 | Dwight R. Stickney, M.D. Chief Medical Officer Robert L. Marsella Senior Vice President, Business Development and Marketing | 230.3K | 46.1K | 6.0K | 199.2K | — | 5.3K | 486.8K | 42.15% | ↗ |
| 33 | 2007 | Robert L. Marsella Senior Vice President, Business Development and Marketing Robert W. Weber Chief Financial Officer | 213.2K | 42.6K | 6.0K | 166.0K | — | 15.6K | 443.3K | 38.80% | ↗ |
| 34 | 2007 | Robert L. Marsella Senior Vice President, Business Development and Marketing | 230.3K | 46.1K | 6.4K | 151.5K | — | 5.3K | 439.5K | 35.93% | ↗ |
| 35 | 2007 | Robert W. Weber Interim Chief Financial Officer, Chief Accounting Officer and Vice President, Operations | 213.2K | 42.6K | 6.4K | 148.3K | — | 15.6K | 426.1K | 36.29% | ↗ |
| 36 | 2006 | Richard B. Hollis Former Chairman of the Board and Chief Executive Officer | 512.0K | 385.0K | 32.8K | 817.1K | — | 936.00 | 1.75M | 48.63% | ↗ |
| 37 | 2006 | Richard B. Hollis Chairman of the Board and Chief Executive Officer | 512.0K | 385.0K | 32.8K | 817.1K | — | 936.00 | 1.75M | 48.63% | ↗ |
| 38 | 2006 | Dr. James M. Frincke Chief Scientific Officer | 287.0K | 57.4K | 12.3K | 326.7K | — | 12.9K | 696.3K | 48.69% | ↗ |
| 39 | 2006 | Richard B. Hollis Former Chairman of the Board and Chief Executive Officer Dr. James M. Frincke Interim Chief Executive Officer | 287.0K | 57.4K | 12.3K | 326.7K | — | 12.9K | 696.3K | 48.69% | ↗ |
| 40 | 2006 | Daniel D. Burgess Chief Financial Officer and Chief Operating Officer | 330.1K | 66.0K | 12.3K | 257.1K | — | 7.5K | 673.0K | 40.03% | ↗ |
| 41 | 2006 | Dr. Christopher L. Reading Chief Scientific Officer Dwight R. Stickney, M.D. Chief Medical Officer | 343.4K | 68.7K | 5.1K | 137.3K | — | 3.1K | 557.6K | 25.55% | ↗ |
| 42 | 2006 | Dr. James M. Frincke Interim Chief Executive Officer Dr. Christopher L. Reading Chief Scientific Officer | 250.1K | 50.0K | 5.1K | 156.3K | — | 7.2K | 468.7K | 34.45% | ↗ |
| 43 | 2006 | Dr. Christopher L. Reading Executive Vice President, Scientific Development | 250.1K | 50.0K | 5.1K | 156.3K | — | 7.2K | 468.7K | 34.45% | ↗ |
| 44 | 2006 | Eric J. Loumeau Vice President, Corporate General Counsel | 261.4K | 52.3K | 5.1K | 127.7K | — | 7.1K | 453.6K | 29.28% | ↗ |
| 45 | 2006 | Dwight R. Stickney, M.D. Chief Medical Officer Robert L. Marsella Senior Vice President, Business Development and Marketing | 221.4K | 44.3K | 5.1K | 100.7K | — | 7.6K | 379.2K | 27.92% | ↗ |
| 46 | 2006 | Robert L. Marsella Senior Vice President, Business Development and Marketing Robert W. Weber Interim Chief Financial Officer, Chief Accounting Officer and Vice President, Operations | 205.0K | 41.0K | 5.1K | 100.7K | — | 9.0K | 360.8K | 29.33% | ↗ |
| 47 | 2005 | Mr. Richard B. Hollis Chairman of the Board, President and Chief Executive Officer | 500.0K | 250.0K | — | 124.8K | — | — | 874.8K | 14.27% | ↗ |
| 48 | 2005 | Mr. Daniel D. Burgess Chief Financial Officer and Chief Operating Officer | 322.0K | 40.0K | — | 39.0K | — | — | 401.0K | 9.73% | ↗ |
| 49 | 2005 | Dr. James M. Frincke Chief Scientific Officer | 280.0K | 40.0K | — | 46.8K | — | — | 366.8K | 12.76% | ↗ |
| 50 | 2005 | Mr. Eric J. Loumeau Vice President, Corporate General Counsel | 255.0K | 35.0K | — | 19.5K | — | — | 309.5K | 6.30% | ↗ |
| 51 | 2005 | Dr. Christopher L. Reading, M.D. Executive Vice President, Scientific Development | 244.0K | 40.0K | — | 19.5K | — | — | 303.5K | 6.43% | ↗ |
| 52 | 2004 | Mr. Richard B. Hollis Chairman of the Board, President and Chief Executive Officer | 485.0K | 325.0K | — | 160.0K | — | — | 970.0K | 16.49% | ↗ |
| 53 | 2004 | Mr. Daniel D. Burgess Chief Financial Officer and Chief Operating Officer | 307.0K | 52.0K | — | 50.0K | — | — | 409.0K | 12.22% | ↗ |
| 54 | 2004 | Dr. Dwight R. Stickney, M.D. Vice President, Medical Affairs | 325.0K | 45.0K | — | 34.0K | — | — | 404.0K | 8.42% | ↗ |
| 55 | 2004 | Dr. James M. Frincke Chief Scientific Officer | 267.0K | 52.0K | — | 64.0K | — | — | 383.0K | 16.71% | ↗ |
| 56 | 2004 | Dr. Christopher L. Reading, M.D. Executive Vice President, Scientific Development | 232.0K | 52.0K | — | 31.0K | — | — | 315.0K | 9.84% | ↗ |
| 57 | 2004 | Mr. Eric J. Loumeau Vice President, Corporate General Counsel | 243.0K | 45.0K | — | 25.0K | — | — | 313.0K | 7.99% | ↗ |
| 58 | 2003 | Mr. Richard B. Hollis Chairman of the Board, President and Chief Executive Officer | 451.0K | 347.0K | — | 240.0K | — | — | 1.04M | 23.12% | ↗ |
| 59 | 2003 | Mr. Daniel D. Burgess Chief Financial Officer and Chief Operating Officer | 285.0K | 58.0K | — | 50.0K | — | — | 393.0K | 12.72% | ↗ |
| 60 | 2003 | Dr. Dwight R. Stickney, M.D. Vice President, Medical Affairs | 307.5K | 47.0K | — | 23.5K | — | — | 378.0K | 6.22% | ↗ |
| 61 | 2003 | Dr. James M. Frincke Chief Scientific Officer | 248.0K | 51.0K | — | 70.0K | — | — | 369.0K | 18.97% | ↗ |
| 62 | 2003 | Dr. Christopher L. Reading, M.D. Executive Vice President, Scientific Development | 215.5K | 65.0K | — | 41.0K | — | — | 321.5K | 12.75% | ↗ |
| 63 | 2003 | Mr. Eric J. Loumeau Vice President, Corporate General Counsel | 225.5K | 46.0K | — | 25.0K | — | — | 296.5K | 8.43% | ↗ |
| 64 | 2002 | Mr. Richard B. Hollis Chairman of the Board, President and Chief Executive Officer | 440.0K | 330.0K | — | 240.0K | — | — | 1.01M | 23.76% | ↗ |
| 65 | 2002 | Mr. Daniel D. Burgess Chief Financial Officer and Chief Operating Officer | 278.0K | 27.8K | — | 50.0K | — | — | 355.8K | 14.05% | ↗ |
| 66 | 2002 | Dr. Dwight R. Stickney, M.D. Vice President, Medical Affairs | 300.0K | 30.0K | — | 12.5K | — | — | 342.5K | 3.65% | ↗ |
| 67 | 2002 | Dr. James M. Frincke Chief Scientific Officer | 242.0K | 24.2K | — | 60.0K | — | — | 326.2K | 18.39% | ↗ |
| 68 | 2002 | Dr. Dwight R. Stickney, M.D. Medical Director, Oncology | 300.0K | — | — | 12.5K | — | — | 312.5K | 4.00% | ↗ |
| 69 | 2002 | Mr. Eric J. Loumeau Vice President, Corporate General Counsel | 225.5K | 46.0K | — | 25.0K | — | — | 296.5K | 8.43% | ↗ |
| 70 | 2002 | Dr. Christopher L. Reading Executive Vice President— Scientific Development | 210.0K | — | — | 60.0K | — | — | 270.0K | 22.22% | ↗ |
| 71 | 2002 | Mr. Eric J. Loumeau Vice President—Corporate General Counsel | 220.0K | — | — | 25.0K | — | — | 245.0K | 10.20% | ↗ |
| 72 | 2001 | Mr. Richard B. Hollis Chairman of the Board, President and Chief Executive Officer | 400.0K | 280.0K | — | — | — | — | 680.0K | 0.00% | ↗ |
| 73 | 2001 | Dr. Dwight R. Stickney, M.D. Medical Director, Oncology | 245.3K | 29.0K | — | 36.0K | — | — | 310.3K | 11.60% | ↗ |
| 74 | 2001 | Dr. Dwight R. Stickney, M.D. Vice President, Medical Affairs | 245.3K | 29.0K | — | 36.0K | — | — | 310.3K | 11.60% | ↗ |
| 75 | 2001 | Mr. Daniel D. Burgess Chief Financial Officer and Chief Operating Officer | 264.0K | 26.4K | — | — | — | — | 290.4K | 0.00% | ↗ |
| 76 | 2001 | Dr. James M. Frincke Chief Scientific Officer | 220.0K | 44.0K | — | — | — | — | 264.0K | 0.00% | ↗ |
| 77 | 2001 | Mr. Eric J. Loumeau Vice President—Corporate General Counsel | 209.0K | 21.0K | — | — | — | — | 230.0K | 0.00% | ↗ |
| 78 | 2001 | Mr. Eric J. Loumeau Vice President, Corporate General Counsel | 209.0K | 21.0K | — | — | — | — | 230.0K | 0.00% | ↗ |
| 79 | 2001 | Dr. Christopher L. Reading Executive Vice President— Scientific Development | 188.5K | 38.0K | — | — | — | — | 226.5K | 0.00% | ↗ |
| 80 | 2001 | Dr. Christopher L. Reading Executive Vice President—Scientific Development | 188.5K | 38.0K | — | — | — | — | 226.5K | 0.00% | ↗ |
| 81 | 2001 | Mr. Robert Marsella Vice President—Business Development | 178.0K | 18.0K | — | — | — | — | 196.0K | 0.00% | ↗ |
| 82 | 2000 | Mr. Richard B. Hollis Chairman of the Board, President and Chief Executive Officer | 363.0K | 250.0K | — | 160.0K | — | 155.0K | 928.0K | 17.24% | ↗ |
| 83 | 2000 | Dr. James M. Frincke Chief Scientific Officer | 200.0K | 40.0K | — | 110.0K | — | — | 350.0K | 31.43% | ↗ |
| 84 | 2000 | Mr. Daniel D. Burgess Chief Financial Officer and Chief Operating Officer | 240.0K | 48.0K | — | 50.0K | — | — | 338.0K | 14.79% | ↗ |
| 85 | 2000 | Mr. Eric J. Loumeau Vice President—Corporate General Counsel | 190.0K | 38.0K | — | 25.0K | — | — | 253.0K | 9.88% | ↗ |
| 86 | 2000 | Mr. Robert Marsella Vice President—Business Development | 161.7K | 33.0K | — | 55.0K | — | — | 249.7K | 22.03% | ↗ |
| 87 | 2000 | Dr. Christopher L. Reading Executive Vice President— Scientific Development | 171.2K | 35.0K | — | 25.0K | — | — | 231.2K | 10.81% | ↗ |
| 88 | 2000 | Dr. Christopher L. Reading Executive Vice President—Scientific Development | 171.2K | 35.0K | — | 25.0K | — | — | 231.2K | 10.81% | ↗ |
| 89 | 2000 | Dr. Dwight R. Stickney, M.D. Medical Director, Oncology | 104.0K | 15.6K | — | 50.0K | — | — | 169.6K | 29.48% | ↗ |
| 90 | 1999 | Mr. Richard B. Hollis Chairman of the Board, President and Chief Executive Officer | 330.0K | 225.0K | — | 426.7K | — | — | 981.7K | 43.46% | ↗ |
| 91 | 1999 | Dr. Christopher L. Reading Executive Vice President—Scientific Development | 160.0K | 24.0K | — | 90.0K | — | 9.2K | 283.2K | 31.78% | ↗ |
| 92 | 1999 | Dr. James M. Frincke Chief Scientific Officer | 181.5K | 37.0K | — | 64.2K | — | — | 282.7K | 22.70% | ↗ |
| 93 | 1999 | Mr. Daniel D. Burgess Chief Financial Officer and Chief Operating Officer | 90.7K | 20.0K | — | 165.0K | — | — | 275.7K | 59.85% | ↗ |
| 94 | 1999 | Mr. Robert Marsella Vice President—Business Development | 147.0K | 30.0K | — | 10.0K | — | — | 187.0K | 5.35% | ↗ |
| 95 | 1999 | Mr. Eric J. Loumeau Vice President—Corporate General Counsel | 51.0K | 50.0K | — | 65.0K | — | — | 166.0K | 39.15% | ↗ |
CEO compensation breakdown
Proxy statements
Proxy statements (DEF 14A)
No proxy statements available for this company yet.
Recent SEC filings
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Robert R. Binns | Chief Executive Officer & President of Air Wisconsin Airlines LLC | 1M | male |
| Gregg Garvey | Executive VP, Treasurer, CFO and Principal Financial & Accounting Officer | 465.7K | male |
| Liam S. Mackay | Chief Financial Officer of Air Wisconsin Airlines LLC | 423.7K | male |
| Robert W. Weber | Chief Accounting Officer, Vice President of Operations & Controller | 242.6K | male |
| Christine R. Deister | CEO & Secretary | 235.0K | female |
| Robert L. Marsella | Senior Vice President of Business Development & Marketing | 222.7K | male |
| Christopher L. Reading | Chief Scientific Officer | 188.8K | — |
| Scott A. Rieger | Vice President of Corporate Communications | — | male |
| Chad Schimmelpfenning | Executive VP & Chief Legal Counsel | — | male |
ESG Rating
ESG Score History AIRLINES, AIRPORTS & AIR SERVICES
Benchmark vs Sector
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
No House trading activity found for this company.
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for HRBR
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
